person reading Dr. Roy D. Baynes, M.D.,PhD's salary history.

Historical salary details - Dr. Roy D. Baynes, M.D.,PhD, Director, Nurix Therapeutics Inc

Dr. Roy D. Baynes, M.D.,PhD is the Director of Nurix Therapeutics Inc.

Dr. Roy D. Baynes, M.D.,Phd

Director

-
Gross Remuneration
  • Current Company

    Nurix Therapeutics Inc
YEAR COMPANY POSITION SALARY INCREMENT
2025 Nurix Therapeutics Inc Director - -
2024 Travere Therapeutics Inc Independent Director 247.3 K -
2024 Aardvark Therapeutics Inc. Independent Director 171.4 K -
2024 Nurix Therapeutics Inc Independent Director - -
2024 Natera Inc Independent Director - -
2023 Natera Inc Independent Director 317.7 K -19.2 %
2023 Travere Therapeutics Inc Independent Director - -
2022 Natera Inc Independent Director 393.3 K 17.7 %
2022 Atara Biotherapeutics Inc Independent Director 352.8 K -0.9 %
2022 Travere Therapeutics Inc Independent Director 321.6 K 13.1 %
2022 Atara Biotherapeutics Inc Independent Director - -
2021 Atara Biotherapeutics Inc Independent Director 356.0 K 17.3 %
2021 Natera Inc Independent Director 334.1 K 7.1 %
2021 Travere Therapeutics Inc Independent Director 284.2 K 13.6 %
2020 Natera Inc Independent Director 311.9 K -3.4 %
2020 Atara Biotherapeutics Inc Independent Director 303.5 K 3.4 %
2020 Travere Therapeutics Inc Independent Director 250.2 K 2.9 %
2019 Natera Inc Independent Director 322.9 K 26.3 %
2019 Atara Biotherapeutics Inc Independent Director 293.6 K -28.6 %
2019 Travere Therapeutics Inc Independent Director 243.2 K -37.9 %
2018 Atara Biotherapeutics Inc Independent Director 411.5 K -
2018 Travere Therapeutics Inc Independent Director 391.5 K 86.0 %
2018 Natera Inc Independent Director 255.6 K -
2017 Travere Therapeutics Inc Independent Director 210.5 K -16.1 %
2016 Travere Therapeutics Inc Independent Director 250.9 K -